Clin2
NCT06742710Possibly a fitRecruiting

Liraglutide for obese infertility in PCOS

PCOSObesityInfertility

Treatments studied

Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.

This trial tests if liraglutide, a weight-loss medication, can help obese women with PCOS who have a frozen embryo achieve pregnancy. It aims to improve fertility outcomes by aiding weight loss before embryo transfer.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
890 people
Ages
20 years to 40 years
Study type
Interventional

Who can take part

  • You are a woman aged 20 to 40 with PCOS
  • You have a body mass index (BMI) between 25 and 35
  • You have at least one frozen embryo stored at the study center
  • You have not used any diabetes or weight-loss drugs (except metformin) in the past 3 months
  • You are willing to follow the study's birth control rules

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06775093Not yet recruiting
Effects of GLP-1 medications on fertility in PCOS and obesity

This trial tests whether a class of drugs called GLP-1 receptor agonists (often used for diabetes and weight loss) can improve pregnancy outcomes in women with polycystic ovary syndrome (PCOS) who are overweight or obese. If you have PCOS and a BMI between 28 and 35, you may be eligible to participate.

Beijing, Beijing Municipality
NCT07687667Not yet recruiting
Glucose-lowering drugs for fertility in women with PCOS

This study tests whether a class of diabetes drugs called GLP-1 receptor agonists can improve fertility in overweight women with polycystic ovary syndrome who want to conceive. These drugs help with weight and blood sugar, which may improve ovulation and pregnancy chances.

Beijing, Beijing Municipality
NCT07242534Recruiting· Phase 4
Semaglutide for better embryos in IVF for women with overweight or obesity

This trial tests whether semaglutide, a medication used for weight management, can improve the quality of embryos in women who are overweight or have obesity and are doing IVF. It aims to see if taking semaglutide before the IVF process helps make healthier embryos that can be frozen for later use.

Sabadell, Barcelona
NCT07811895Not yet recruiting
Weight-loss drug before frozen embryo transfer in obese women

This trial tests a once-weekly injection that helps with weight loss and may improve the chances of a successful frozen embryo transfer in women with obesity. It aims to see if losing weight before the transfer leads to better pregnancy outcomes.

Shanghai, Shanghai Municipality
NCT07159880Recruiting
Letrozole for ovulation induction in PCOS

This trial tests a longer course of letrozole to help women with PCOS ovulate and get pregnant. The goal is to see if extended therapy works better than the standard treatment.

São Paulo, São Paulo
NCT06587698Recruiting
Study of sitagliptin or BeiDouGen capsule for PCOS pregnancy

This trial tests if sitagliptin or BeiDouGen capsule can improve pregnancy outcomes in women with PCOS. It aims to help those planning to conceive or struggling with infertility.

Beijing, Beijing Municipality

Hear when a new Obesity trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.